Pharmacology (4 years) [MSci]
University of ManchesterPharmacology (4 years) [MSci] MSci is an integrated masters undergraduate degree at University of Manchester, based in Manchester, taught full-time over 4 years. Graduates earn £24,000 on average 15 months after finishing. Typical A-level entry is AAA - AAB.
A-Level Entry
AAA - AAB
Typical offer · UCAS
Avg. Graduate Salary
£24,000
15 months after graduation · HESA via Discover Uni
About this course
Our MSci Pharmacology course will enable you to achieve an integrated master's degree while you study for a BSc, giving you significant research experience that will be invaluable for a PhD and a career in research.
You will explore drug actions on living systems - where they act, what they do, how they are metabolised, and how they exert toxic effects.
Understanding all of this requires studying drug actions at levels ranging from the single molecule to the whole organism.
As a result, our course includes aspects of molecular biology, chemistry, physiology and neuroscience, and you will examine both the actions of current drugs and the development of new drugs throughout the course.
In Year 4, you will undertake a major research project in one of the University's research labs to achieve your undergraduate master's award.
Our course has Advanced Accreditation from the Royal Society of Biology , which recognises academic excellence in the biosciences and highlights degrees that educate the research and development leaders and innovators of the future.
Entry Requirements
Career Prospects
Graduates from this course typically go into the following occupations. Click through for salaries, employment rates and other UK degrees that lead there:
Related Courses
Course Details
- Qualification
- Master of Science - MSci
- Study Mode
- Full-time
- Duration
- 4 Years
- Start Date
- 2025
- Academic Year
- 2025
- Campus / Location
- Manchester
- Scheme
- Undergraduate (Integrated Masters)
- Subjects
- Pharmacy, pharmacology, and toxicology
- Avg. Graduate Salary
- £24,000
2025-entry data — 2026 offers may differ